Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ROCKET PHARMACEUTICALS, INC.

(RCKT)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Rocket Pharmaceuticals : Significant Insider Selling Reported in Shares of Rocket Pharmaceuticals (RCKT)

05/14/2021 | 10:22pm EDT


ę MT Newswires 2021
All news about ROCKET PHARMACEUTICALS, INC.
06/22ROCKET PHARMACEUTICALS : Significant Insider Selling Continues at Rocket Pharmac..
MT
06/22ROCKET PHARMACEUTICALS : Insider at Rocket Pharmaceuticals (RCKT) Makes Signific..
MT
06/21INSIDER TRENDS : Rocket Pharmaceuticals Insider Continues 90-Day Selling Trend
MT
06/21ROCKET PHARMACEUTICALS, INC. : Submission of Matters to a Vote of Security Holde..
AQ
05/14ROCKET PHARMACEUTICALS : Significant Insider Selling Reported in Shares of Rocke..
MT
05/13INSIDER TRENDS : Rocket Pharmaceuticals Insider Extends 90-Day Selling Trend
MT
05/13ROCKET PHARMACEUTICALS : Presents Positive Clinical Data from Fanconi Anemia, Le..
BU
05/13Rocket Pharmaceuticals, Inc. Presents Positive Clinical Data from Fanconi Ane..
CI
05/12ROCKET PHARMACEUTICALS : —Updated Low Dose Results in RP-A501 Treatment fo..
PU
05/11SECTOR UPDATE : Health Care Stocks Ending Tuesday Session Lower, But Biotech Sha..
MT
More news
Financials (USD)
Sales 2021 10,0 M - -
Net income 2021 -162 M - -
Net cash 2021 282 M - -
P/E ratio 2021 -15,0x
Yield 2021 -
Capitalization 2 471 M 2 471 M -
EV / Sales 2021 218x
EV / Sales 2022 71,7x
Nbr of Employees 91
Free-Float 90,9%
Chart ROCKET PHARMACEUTICALS, INC.
Duration : Period :
Rocket Pharmaceuticals, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ROCKET PHARMACEUTICALS, INC.
Short TermMid-TermLong Term
TrendsBearishBearishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 11
Last Close Price 38,98 $
Average target price 70,70 $
Spread / Average Target 81,4%
EPS Revisions
Managers and Directors
Gaurav Shah President, Chief Executive Officer & Director
Carlos Garcia-Parada Chief Financial Officer
Roderick T. Wong Chairman
Jonathan David Schwartz Chief Medical Officer & SVP-Clinical Development
Kinnari Patel Chief Operating Officer & EVP-Development
Sector and Competitors
1st jan.Capi. (M$)
ROCKET PHARMACEUTICALS, INC.-28.92%2 471
GILEAD SCIENCES, INC.18.01%86 563
BIONTECH SE251.15%69 138
WUXI APPTEC CO., LTD.32.49%67 035
REGENERON PHARMACEUTICALS19.60%59 833
VERTEX PHARMACEUTICALS-15.83%51 496